Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Operating Margin (2009 - 2026)

Updated

Alnylam Pharmaceuticals (ALNY) reported Operating Margin of 17.93% for Q2 2026, up 20.02 percentage points from -2.09% a year earlier but down 5.09 percentage points from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) Operating Margin (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Alnylam Pharmaceuticals' Operating Margin came in at 20.81%, up 30.31 percentage points year-over-year; for FY2025, it was 13.51%, up 21.37 percentage points from FY2024.

  • Operating Margin has increased for seven consecutive years, with a five-year change of +181.60 percentage points (FY2020 to FY2025).
  • By year, Operating Margin came in at -7.87% in FY2024 (+7.57 pp), -15.43% in FY2023 (+60.24 pp), -75.68% in FY2022 (+8.26 pp) and -83.93% in FY2021 (+84.16 pp).
  • Five-year quarterly Operating Margin spans a low of -97.63% in Q3 2022 and a high of 60.26% in Q1 2025.
  • Year over year, Operating Margin gained in five of the last eight quarters, with an average year-over-year change of +10.23 percentage points.
  • The high point for year-over-year Operating Margin in five years was Q3 2023 (a gain of 126.12 percentage points); the low point was Q3 2024 (a drop of 43.85 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 23.02% (Q1 2026), 12.01% (Q4 2025) and 29.46% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 28.21%
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 37.86%
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn -3.52%
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 32.97%
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 20.57%
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 34.95%
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -133.21%
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 37.40%
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn 17.93%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.93%
Mar 31, 2026 23.02%
Dec 31, 2025 12.01%
Sep 30, 2025 29.46%
Jun 30, 2025 -2.09%
Dec 31, 2024 -17.73%
Sep 30, 2024 -15.35%
Jun 30, 2024 7.37%
Mar 31, 2024 -8.79%
Dec 31, 2023 -26.47%
Sep 30, 2023 28.50%
Jun 30, 2023 -72.10%
Mar 31, 2023 -46.92%
Dec 31, 2022 -56.30%
Sep 30, 2022 -97.63%
Jun 30, 2022 -85.26%
Mar 31, 2022 -68.80%
Dec 31, 2021 -75.26%
Sep 30, 2021 -96.83%
Jun 30, 2021 -66.27%
API Access

Alnylam Pharmaceuticals Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=ALNY&period=max&api_key=YOUR_API_KEY